As Product Development Scientist, Cian Hill is responsible for devising product formulation, manufacturing, and quality strategies for microbiome projects, which support and integrate into overall product development plans. He is also responsible for continued landscape analysis of microbiome innovation, globally.
Cian joined the JHMI team following more than two years with Johnson & Johnson (J&J) Sterility Assurance as part of the presitigous GOLD (Global Operations Leadership Development) program, which consisted of three placements across the J&J enterprise.
Cian’s first placement was in DePuy Synthes Ireland, working within the Quality Department as a member of the microbiology team. In this role, he gained knowledge of the quality regualtions for GMP manufacturing of medical devices and participated in a wide range of sterilization modalities.
He then moved to pharmecutical research and development within Drug Product Development at Janssen in Beerse, Belgium, where he focused on small molecule therapies. This role included work on an internal human microbiota pre-clinical microbiome drug, involving manufacturing capability development, method optimization, and preparation for a Phase 1 clinical trial. Cian spent his final GOLD assignment in Product Development & Manufaturing Sciences at Janssen in Cork, Ireland, where he focused on large molecule therapies with a primary responsibility on new product introduction processes and manufacturing of novel clinical trial material (Phases 1a – 2b).
Cian holds a Bachelors of Science in Genetics from University College Cork (Ireland). He obtained his Ph.D., with a focus on the gut microbiota of infants, from the same institution, in conjunction with the Alimentary Pharmabiotic Centre and Teagasc.